
Swarm Oncology and Cellex partner to accelerate T cell therapies
Swarm Oncology and Cellex Cell Professionals have announced a new partnership with a particular focus on clinical and commercial supply of T cell therapies. Despite advancements in oncology, more than 82% of patients with advanced metastatic cancer ultimately succumb to their disease. Current immunotherapies provide… Read More















